中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
Author:(Hetong YU)

1.Research Progress on the Risk of Excipients-Related Adverse Reactions in Pharmaceutical Preparations for IBD Treatment

Yanru ZHANG ; Qiuyue TU ; Ping WANG ; Zelin FENG ; Huizhen LI ; Yushan ZHU ; Haojia LIN ; Xinyue WEI ; Qinghua YI ; Hetong ZHANG ; Yueting LI ; Xiaoqin LI ; Yu WANG ; Dong XIE ; Xiaocang CAO

Medical Journal of Peking Union Medical College Hospital 2026;17(4):1135-1142

2.Pharmacovigilance Signal Mining and Analysis of Ustekinumab versus Upadacitinib for Inflammatory Bowel Disease Based on the FAERS Database

Dong XIE ; Yu WANG ; Haojia LIN ; Qiuyue TU ; Hetong ZHANG ; Huizhen LI ; Qinghua YI ; Zhengxiang LI ; Hengjie YUAN ; Xiaocang CAO

Medical Journal of Peking Union Medical College Hospital 2025;16(6):1376-1383

3.Protein-based Bioinformatics Analysis of Cervical Cancer Related Genes

Lingjing CHENG ; Hetong LI ; Shengxiao ZHANG ; Hongqi LIU ; Qi YU ; Chaoyue ZHENG ; Shuang FENG ; Teng KONG ; Xiangfei SUN ; Peifeng HE ; Xiaoping LYU

Journal of Medical Informatics 2023;44(12):47-54

4. The application of artificial dermis in repairing partial fingernail bed defect

Shaohua LIU ; Zhanbei MA ; Hetong YU ; Liang MA ; Yuechuang LIANG ; Yu WU ; Dongyue LI ; Chong NAN ; Huanhuan ZHAO ; Xiaowei REN ; Lie HUO

Chinese Journal of Plastic Surgery 2018;34(11):955-958

5.Relationship between transforming growth factor gene single nucleotide polymorphisms and susceptibility of lung cancer

Lu BAI ; Hong YU ; Hetong WANG ; Yuxia ZHAO

Chinese Journal of Postgraduates of Medicine 2016;39(4):292-295

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO